会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Hydroxyphenyl cross-linked macromolecular network and applications thereof
    • 羟基苯基交联大分子网络及其应用
    • US20050265959A1
    • 2005-12-01
    • US11198803
    • 2005-08-05
    • Anthony CalabroRichard GrossAniq Darr
    • Anthony CalabroRichard GrossAniq Darr
    • A61K31/74A61K31/765A61K47/34A61K47/36A61K47/42A61L27/14A61L27/52C08F261/02C08G63/48C08G63/81C08G63/91C08G73/02C08L71/00C12Q20060101
    • A61L27/52A61K47/34A61K47/36A61K47/42A61L27/14C08G63/81C08G73/02C08J3/075C08L101/14
    • A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, such as artificial or synthetic cartilage. The network is made by first providing a polyamine or polycarboxylate macromolecule (having a plurality of amine or carboxylic acid groups respectively attached along the length of the molecule), reacting this macromolecule with a hydroxyphenyl compound having a free carboxylic acid group in the case of a polyamine or a free primary amine group in the case of a polycarboxylate, and substituting the hydroxyphenyl compound onto the macromolecule via a carbodiimide-mediated reaction pathway to provide a hydroxyphenyl-substituted macromolecule. This macromolecule is then linked to other such macromolecules via an enzyme catalyzed dimerization reaction between two hydroxyphenyl groups attached respectively to different macromolecules under metabolic conditions of temperature and pH. In a preferred embodiment, the macromolecular network is made up of tyramine-substituted hyaluronan molecules that are linked by dityramine bonds to provide a stable, coherent hydrogel with desired physical properties. A method of preparing such a network is also provided.
    • 提供二羟基苯基交联的大分子网络,其可用于人造或组织工程应用,例如人造或合成软骨。 通过首先提供多胺或多羧酸盐大分子(沿着分子长度分别具有多个胺或羧酸基团)制备网络,使该高分子与具有游离羧酸基团的羟基苯基化合物反应 多胺或游离的伯胺基,并且通过碳二亚胺介导的反应途径将羟基苯基化合物取代到大分子上以提供羟基苯基取代的大分子。 然后通过在温度和pH值的代谢条件下分别连接到不同的大分子上的两个羟基苯基之间的酶催化的二聚反应将该大分子连接到其它这样的大分子。 在优选的实施方案中,大分子网络由酪胺取代的透明质酸分子组成,其通过二苯胺键连接以提供具有所需物理性质的稳定的,连贯的水凝胶。 还提供了一种制备这种网络的方法。
    • 3. 发明授权
    • Adjustable ear clip
    • 可调式耳夹
    • US5551259A
    • 1996-09-03
    • US437574
    • 1995-05-09
    • Anthony Calabro
    • Anthony Calabro
    • A44C7/00
    • A44C7/006Y10T24/44504
    • An adjustable ear clip device for relieving pressure on the ear lobe of a wearer is provided. The adjustable ear clip includes a base member with a pair of spaced ears connected thereto. An angled stop plate is connected to the base plate and a mounting plate is connected to the angled stop plate to receive an ornamental member. An ear engaging member includes a pair of spring-biased arms for engaging the ears. A spring tongue is positioned between the arms and has a stop bolt aperture therethrough. A stop bolt is threaded through the spring tongue and engages with the angled stop plate to limit the travel of the ear engaging member toward the ornamental member.
    • 提供了用于缓解佩戴者耳垂上的压力的可调式耳夹装置。 可调节的耳夹包括具有连接到其上的一对隔开的耳朵的基座构件。 倾斜的止动板连接到基板,并且安装板连接到成角度的止动板以接收装饰构件。 耳朵接合构件包括用于接合耳朵的一对弹簧偏压臂。 弹簧舌片位于臂之间并且具有穿过其中的止动螺栓孔。 止动螺栓穿过弹簧舌片并与成角度的止动板接合以限制耳朵接合构件朝向装饰构件的行进。
    • 5. 发明申请
    • Compositions and methods to treat urinary incontinence
    • 治疗尿失禁的组成和方法
    • US20090274678A1
    • 2009-11-05
    • US12387256
    • 2009-04-30
    • Anthony CalabroAniq B. DarrFirouz Daneshgari
    • Anthony CalabroAniq B. DarrFirouz Daneshgari
    • A61K38/44A61K38/39A61P13/00A61K33/40
    • A61K38/39A61L31/044A61L2400/06
    • A method is disclosed for treatment of urinary incontinence. The method includes the steps of providing to a person or animal, in the vicinity of a pubo-urethral ligament of the person or animal, a composition including collagen macromolecules that have hydroxyphenyl side groups substituted thereon, which are reacted to form dihydroxyphenyl linkages. In an embodiment, the collagen macromolecules are gelatin macromolecules. In another embodiment, the hydroxyphenyl side groups are tyramine side groups and the dihydroxyphenyl linkages are dityramine linkages. The composition can be injected into a space between a urethra and a pubis of the person or animal wherein the pubo-urethral ligament is disposed in the space. The method is advantageous, for example, based on being minimally invasive.
    • 公开了一种治疗尿失禁的方法。 该方法包括以下步骤:向人或动物在人或动物的尿道韧带附近提供包含其上被羟基苯基侧基取代的胶原大分子的组合物,其被反应以形成二羟基苯基键。 在一个实施方案中,胶原大分子是明胶大分子。 在另一个实施方案中,羟基苯基侧基是酪胺侧基,二羟基苯基键是二联苯胺键。 组合物可以注射到尿道和人或动物的耻骨之间的空间中,其中尿道 - 尿道韧带设置在该空间中。 该方法是有利的,例如,基于微创。
    • 8. 发明授权
    • Hydroxyphenyl cross-linked macromolecular network and applications thereof
    • 羟基苯基交联大分子网络及其应用
    • US07368502B2
    • 2008-05-06
    • US11198803
    • 2005-08-05
    • Anthony CalabroRichard A. GrossAniq B. Darr
    • Anthony CalabroRichard A. GrossAniq B. Darr
    • C08L89/00C08G63/48
    • A61L27/52A61K47/34A61K47/36A61K47/42A61L27/14C08G63/81C08G73/02C08J3/075C08L101/14
    • A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, such as artificial or synthetic cartilage. The network is made by first providing a polyamine or polycarboxylate macromolecule (having a plurality of amine or carboxylic acid groups respectively attached along the length of the molecule), reacting this macromolecule with a hydroxyphenyl compound having a free carboxylic acid group in the case of a polyamine or a free primary amine group in the case of a polycarboxylate, and substituting the hydroxyphenyl compound onto the macromolecule via a carbodiimide-mediated reaction pathway to provide a hydroxyphenyl-substituted macromolecule. This macromolecule is then linked to other such macromolecules via an enzyme catalyzed dimerization reaction between two hydroxyphenyl groups attached respectively to different macromolecules under metabolic conditions of temperature and pH. In a preferred embodiment, the macromolecular network is made up of tyramine-substituted hyaluronan molecules that are linked by dityramine bonds to provide a stable, coherent hydrogel with desired physical properties. A method of preparing such a network is also provided.
    • 提供二羟基苯基交联的大分子网络,其可用于人造或组织工程应用,例如人造或合成软骨。 通过首先提供多胺或多羧酸盐大分子(沿着分子长度分别具有多个胺或羧酸基团)制备网络,使该高分子与具有游离羧酸基团的羟基苯基化合物反应 多胺或游离的伯胺基,并且通过碳二亚胺介导的反应途径将羟基苯基化合物取代到大分子上以提供羟基苯基取代的大分子。 然后通过在温度和pH值的代谢条件下分别连接到不同大分子上的两个羟基苯基之间的酶催化的二聚反应将该大分子连接到其它这样的大分子。 在优选的实施方案中,大分子网络由酪胺取代的透明质酸分子组成,其通过二苯胺键连接以提供具有所需物理性质的稳定的,连贯的水凝胶。 还提供了一种制备这种网络的方法。
    • 9. 发明授权
    • Treatment of extracellular matrix to reduce inflammation
    • 细胞外基质的治疗以减少炎症
    • US08658593B2
    • 2014-02-25
    • US13489974
    • 2012-06-06
    • Anthony CalabroMark LauerVincent Hascall
    • Anthony CalabroMark LauerVincent Hascall
    • A61K47/00A61P19/00A61P29/00
    • A61K31/728A61K38/1709A61K38/191A61K2300/00
    • Pharmaceutical compositions are provided. The compositions comprise a compound comprising the hyaluronan-containing structure A-(low molecular weight hyaluronan domain)-B. The compositions also comprise a pharmaceutically acceptable excipient. A is hydrogen, a substituent that does not comprise a binding site for tumor necrosis factor stimulated gene-6 (“TSG-6”) protein, a substituent that interferes with binding of TSG-6 protein immediately adjacent thereto, or chondroitin. B is hydroxyl, a substituent that does not comprise a binding site for TSG-6 protein, a substituent that interferes with binding of TSG-6 protein immediately adjacent thereto, or chondroitin. The composition is suitable for administration by injection, inhalation, topical rub, or ingestion. Also disclosed are methods and kits for treating a site of inflammation in an individual in need thereof and for decreasing heavy chain modification of pathological hyaluronan at a site of inflammation in an individual in need thereof based on administering the compounds or the compositions.
    • 提供药物组合物。 组合物包含含有透明质酸的结构A-(低分子量透明质酸结构域)-B的化合物。 组合物还包含药学上可接受的赋形剂。 A是氢,不包含肿瘤坏死因子刺激的基因-6(“TSG-6”)蛋白的结合位点的取代基,干扰与其相邻的TSG-6蛋白的结合的取代基或软骨素。 B是羟基,不包含TSG-6蛋白的结合位点,干扰与其紧邻的TSG-6蛋白的结合的取代基或软骨素的取代基。 该组合物适用于通过注射,吸入,局部擦拭或摄入进行给药。 还公开了用于治疗有需要的个体的炎症部位的方法和试剂盒,并且基于施用化合物或组合物,减少有需要的个体的炎症部位的病理性透明质酸的重链修饰。